The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life

2008 ◽  
Vol 17 (9) ◽  
pp. 948-953 ◽  
Author(s):  
E. Forrest Morrill ◽  
Noel T. Brewer ◽  
Suzanne C. O'Neill ◽  
Sarah E. Lillie ◽  
E. Claire Dees ◽  
...  
2019 ◽  
Vol 2 (2) ◽  
pp. 29-35 ◽  
Author(s):  
O Zsigmond ◽  
A Vargay ◽  
E Józsa ◽  
É Bányai

Purpose The purpose of this study was to explore the factors influencing post-traumatic growth in breast cancer patients during 3 years after diagnosis. Materials and methods Our longitudinal study involved 71 medium and high-risk breast cancer patients, who received special attention and either hypnosis or music psychological intervention while receiving the same chemotherapy protocol. The influences of the interventions, as well as the demographic (age, marital status, and educational level) and psychosocial factors (coping, post-traumatic stress, and well-being), on post-traumatic growth were explored. Results The results showed that over 97% of our patients experienced post-traumatic growth. It was positively associated with Quality of Life domains 3 years after diagnosis, and with Psychological Immune Competence cumulative scores after treatment and 3 years after diagnosis. Psychological Immune Competence, emotional severity of post-traumatic stress symptoms, and the social support scale of Quality of Life explained 33.9% of the variance of post-traumatic growth. Conclusion The results confirm that positive coping strategies, emotional severity of post-traumatic stress symptoms, and social support contribute to post-traumatic growth, and that post-traumatic growth has a weak to moderate association with quality of life.


2021 ◽  
Vol 12 ◽  
Author(s):  
Yuan Yuan ◽  
Zi-Han Liu ◽  
Yan-Jie Zhao ◽  
Qinge Zhang ◽  
Ling Zhang ◽  
...  

Background: The prevalence of post-traumatic stress symptoms (PTSS) in COVID-19 survivors is unclear. This study examined the prevalence of PTSS and its association with quality of life (QOL) among COVID-19 survivors during the post-COVID-19 era in China.Methods: This was a comparative, cross-sectional study. PTSS, depressive symptoms, and QOL were assessed with standardized instruments.Results: A total of 134 COVID-19 survivors and 214 non-infected controls (healthy controls hereafter) were recruited. Among COVID-19 survivors, the PTSS prevalence was 18.66% (95%CI: 11.98–25.34%), which was significantly higher than that (5.61%, 95%CI: 2.50–8.71%) of healthy controls (P < 0.001). After controlling for covariates, an analysis of covariance (ANCOVA) showed that COVID-19 survivors had a higher PTSS total score than did healthy controls [F(1,348) = 4.664, P = 0.032]. A separate ANCOVA revealed there were no significant differences in overall QOL between COVID-19 survivors with and without PTSS [F(1,348) = 1.067, P = 0.304]. A multiple logistic regression analysis showed that more severe depressive symptoms were significantly associated with PTSS in COVID-19 survivors (OR = 1.425, P < 0.001).Conclusions: PTSS were more severe in COVID-19 survivors compared to healthy controls in the post-COVID-19 era. Considering their negative impact on daily life and functional outcomes, regular assessment and appropriate treatments of PTSS should be conducted in COVID-19 survivors.


2019 ◽  
Vol Volume 10 ◽  
pp. 49-58
Author(s):  
M Graça Pereira ◽  
José C Machado ◽  
Marta Pereira ◽  
Cristiana Lopes ◽  
Susana Pedras

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
T. Dolev ◽  
S. Zubedat ◽  
Z. Brand ◽  
B. Bloch ◽  
E. Mader ◽  
...  

AbstractLack of established knowledge and treatment strategies, and change in work environment, may altogether critically affect the mental health and functioning of physicians treating COVID-19 patients. Thus, we examined whether treating COVID-19 patients affect the physicians’ mental health differently compared with physicians treating non-COVID-19 patients. In this cohort study, an association was blindly computed between physiologically measured anxiety and attention vigilance (collected from 1 May 2014 to 31 May 31 2016) and self-reports of anxiety, mental health aspects, and sleep quality (collected from 20 April to 30 June 2020, and analyzed from 1 July to 1 September 2020), of 91 physicians treating COVID-19 or non-COVID-19 patients. As a priori hypothesized, physicians treating COVID-19 patients showed a relative elevation in both physiological measures of anxiety (95% CI: 2317.69–2453.44 versus 1982.32–2068.46; P < 0.001) and attention vigilance (95% CI: 29.85–34.97 versus 22.84–26.61; P < 0.001), compared with their colleagues treating non-COVID-19 patients. At least 3 months into the pandemic, physicians treating COVID-19 patients reported high anxiety and low quality of sleep. Machine learning showed clustering to the COVID-19 and non-COVID-19 subgroups with a high correlation mainly between physiological and self-reported anxiety, and between physiologically measured anxiety and sleep duration. To conclude, the pattern of attention vigilance, heightened anxiety, and reduced sleep quality findings point the need for mental intervention aimed at those physicians susceptible to develop post-traumatic stress symptoms, owing to the consequences of fighting at the forefront of the COVID-19 pandemic.


Sign in / Sign up

Export Citation Format

Share Document